GDIV - ETF AI Analysis
Top Page
Harbor Dividend Growth Leaders ETF (GDIV)
GDIV, the Harbor Dividend Growth Leaders ETF, is supported by high-quality holdings like Microsoft and Apple, which bring strong financial performance, leadership in key growth areas such as cloud, AI, and services, and generally positive long-term outlooks. Several other core positions, including Johnson & Johnson and Gilead Sciences, add stability through solid profitability and favorable earnings call sentiment, though names like Eli Lilly and Mitsubishi UFJ introduce some risk with higher leverage and cash flow challenges. The main risk factor is that many holdings share issues like high valuation or leverage, which could weigh on returns if market conditions turn less favorable.
GDIV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 237.89M
- Region
- Developed Markets
- Expense Ratio
- 0.50%
- Beta
- 0.82
- Issuer
- Harbor
- Inception Date
- May 23, 2022
- Dividend Yield
- 1.24%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
GDIV Summary
Harbor Dividend Growth Leaders ETF (GDIV) is a U.S.-focused fund that invests in large, established companies known for steadily increasing their dividends, rather than tracking a specific index. It spreads money across many sectors, including financials, health care, and technology, with well-known names like Apple, Microsoft, Johnson & Johnson, and Coca-Cola among its top holdings. Someone might invest in GDIV to seek a mix of long-term growth and rising income from dividends in one diversified fund. A key risk is that stock prices and dividend payments can still go up and down with the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.50%, which means you’ll pay about $5 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because GDIV is actively managed, with professionals selecting dividend growth leaders rather than simply tracking a broad market index.
What would affect this ETF?
GDIV could benefit if large, established companies in sectors like financials, health care, and technology keep growing their profits and dividends, especially as global developed markets remain stable and demand for reliable income stays strong. On the other hand, rising interest rates, economic slowdowns, or tighter regulations on banks, drug makers, or big tech firms could pressure the fund’s top holdings such as Apple, Microsoft, and Eli Lilly and weigh on future returns.
GDIV Top 10 Holdings
GDIV is leaning on a mix of dividend-friendly giants, with health care and tech doing much of the heavy lifting. Eli Lilly, Johnson & Johnson, and Gilead are rising steadily, giving the fund a strong defensive backbone, while Microsoft and Apple add growth flair with solid, if sometimes mixed, momentum. On the flip side, industrial name Mueller Industries has been lagging lately, acting as a small drag. Financial exposure is notable too, especially via Japanese banks like Mitsubishi UFJ and Sumitomo Mitsui, giving this largely developed-markets fund a global, income-focused flavor.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 4.78% | $11.61M | $4.84T | 29.43% | 79Outperform |
 LLY | Eli Lilly & Co | 5.03% | $12.21M | $1.33T | 56.36% | 72Outperform |
 MLI | Mueller Industries | 3.18% | $7.71M | $12.11B | 2.93% | 78Outperform |
 JNJ | Johnson & Johnson | 3.13% | $7.59M | $640.75B | 47.88% | 78Outperform |
 MSFT | Microsoft | 3.34% | $8.10M | $3.87T | 8.06% | 79Outperform |
 WMB | Williams Co | 2.88% | $7.00M | $90.60B | 20.08% | 76Outperform |
 KO | Coca-Cola | 2.93% | $7.10M | $407.82B | 39.53% | 75Outperform |
 GILD | Gilead Sciences | 2.75% | $6.69M | $207.72B | 41.85% | 78Outperform |
 MUFG | Mitsubishi UFJ | 2.58% | $6.27M | $241.03B | 45.79% | 77Outperform |
 SMFG | Sumitomo Mitsui | 2.57% | $6.24M | $151.36B | 52.60% | 76Outperform |
GDIV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GDIV, the sentiment is Positive. The current price of 18.91 is above the 20-day moving average (MA) of 18.45, above the 50-day MA of 18.51, and above the 200-day MA of 18.08, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 63.30 is Neutral, neither overbought nor oversold. The STOCH value of 76.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GDIV.
GDIV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| GDIV | $18.91 | $20.50(8.41% Upside) | $237.89M | 0.50% | 73Outperform |
 TILC | $25.28 | $30.12(19.14% Upside) | $879.25M | 0.52% | 63Neutral |
 KNO | $64.09 | $82.14(28.16% Upside) | $43.06M | 0.75% | 69Neutral |
 TNXT | $28.17 | $38.69(37.34% Upside) | $18.69M | 0.49% | 69Neutral |
 RW | $25.87 | $29.16(12.70% Upside) | $16.83M | 0.95% | 63Neutral |
 HDMV | $38.73 | $41.30(6.62% Upside) | $15.14M | 0.80% | 61Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GDIV | Harbor Dividend Growth Leaders ETF | 18.91 | 2.97 | 18.60% | |
| TILC | Thrivent International Large Cap ETF | 25.28 | -0.06 | -0.25% | |
| KNO | AXS Knowledge Leaders ETF | 64.09 | 14.10 | 28.22% | |
| TNXT | T. Rowe Price Innovation Leaders ETF | 28.17 | 3.32 | 13.36% | |
| RW | Rainwater Equity ETF | 25.87 | 0.68 | 2.70% | |
| HDMV | First Trust Horizon Managed Volatility Developed Intl ETF | 38.73 | 5.32 | 15.94% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.